Cancer Research SABCS  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 5692-5694, November 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Gorman, D. B.
Right arrow Articles by Scott, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Gorman, D. B.
Right arrow Articles by Scott, C. D.
[Cancer Research 59, 5692-5694, November 15, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Decreased Insulin-like Growth Factor-II/Mannose 6-Phosphate Receptor Expression Enhances Tumorigenicity in JEG-3 Cells

David B. O’Gorman, Michael Costello, Jocelyn Weiss, Sue M. Firth and Carolyn D. Scott1

Kolling Institute of Medical Research, University of Sydney and Royal North Shore Hospital, St. Leonards, NSW 2065, Australia

The insulin-like growth factor-II/mannose-6 phosphate receptor (IGF-II/M6PR) is believed to bind and degrade the potent mitogen IGF-II, a growth factor for many tumors. This receptor has been shown to be mutated and/or lost in a significant percentage of a variety of tumors, implying that it may act as a negative regulator of cell growth. In this study, we demonstrate that down-regulation of this receptor, mediated by antisense IGF-II/M6PR cDNA transfection into JEG-3 choriocarcinoma cells, results in increased growth rate in vitro and increased tumor growth rate in vivo. These findings demonstrate that a decrease in IGF-II/M6PR expression results in a growth advantage in JEG-3 cells and are consistent with the hypothesis that the IGF-II/M6PR is an inhibitor of tumor growth.




This article has been cited by other articles:


Home page
The OncologistHome page
S. Y. Kim, J. A. Toretsky, D. Scher, and L. J. Helman
The Role of IGF-1R in Pediatric Malignancies
Oncologist, January 1, 2009; 14(1): 83 - 91.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
L.E. Diaz, Y-C. Chuan, M. Lewitt, L. Fernandez-Perez, S. Carrasco-Rodriguez, M. Sanchez-Gomez, and A. Flores-Morales
IGF-II regulates metastatic properties of choriocarcinoma cells through the activation of the insulin receptor
Mol. Hum. Reprod., August 1, 2007; 13(8): 567 - 576.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. L. Wise and D. D. Pravtcheva
Delayed Onset of Igf2-Induced Mammary Tumors in Igf2r Transgenic Mice
Cancer Res., February 1, 2006; 66(3): 1327 - 1336.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C Gicquel, J Weiss, J Amiel, V Gaston, Y Le Bouc, and C D Scott
Epigenetic abnormalities of the mannose-6-phosphate/IGF2 receptor gene are uncommon in human overgrowth syndromes
J. Med. Genet., January 1, 2004; 41(1): e4 - 4.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. N. Szentirmay, H.-X. Yang, S. A. Pawar, C. Vinson, and M. Sawadogo
The IGF2 Receptor Is a USF2-specific Target in Nontumorigenic Mammary Epithelial Cells but Not in Breast Cancer Cells
J. Biol. Chem., September 26, 2003; 278(39): 37231 - 37240.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Kreiling, J. C. Byrd, R. J. Deisz, I. F. Mizukami, R. F. Todd III, and R. G. MacDonald
Binding of Urokinase-type Plasminogen Activator Receptor (uPAR) to the Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor: CONTRASTING INTERACTIONS OF FULL-LENGTH AND SOLUBLE FORMS OF uPAR
J. Biol. Chem., May 30, 2003; 278(23): 20628 - 20637.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. S. Schaffer, M.-F. Lin, J. C. Byrd, J. H. Y. Park, and R. G. MacDonald
Opposing Roles for the Insulin-Like Growth Factor (IGF)-II and Mannose 6-Phosphate (Man-6-P) Binding Activities of the IGF-II/Man-6-P Receptor in the Growth of Prostate Cancer Cells
Endocrinology, March 1, 2003; 144(3): 955 - 966.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. A. Wylie, D. J. Pulford, A. J. McVie-Wylie, R. A. Waterland, H. K. Evans, Y.-T. Chen, C. M. Nolan, T. C. Orton, and R. L. Jirtle
Tissue-Specific Inactivation of Murine M6P/IGF2R
Am. J. Pathol., January 1, 2003; 162(1): 321 - 328.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. B. O'Gorman, J. Weiss, A. Hettiaratchi, S. M. Firth, and C. D. Scott
Insulin-Like Growth Factor-II/Mannose 6-Phosphate Receptor Overexpression Reduces Growth of Choriocarcinoma Cells in Vitro and in Vivo
Endocrinology, November 1, 2002; 143(11): 4287 - 4294.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. R. Kalli, O. I. Falowo, L. K. Bale, M. A. Zschunke, P. C. Roche, and C. A. Conover
Functional Insulin Receptors on Human Epithelial Ovarian Carcinoma Cells: Implications for IGF-II Mitogenic Signaling
Endocrinology, September 1, 2002; 143(9): 3259 - 3267.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. Yu and T. Rohan
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
J Natl Cancer Inst, September 20, 2000; 92(18): 1472 - 1489.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
Endocr. Rev., June 1, 2000; 21(3): 215 - 244.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Linnell, G. Groeger, and A. B. Hassan
Real Time Kinetics of Insulin-like Growth Factor II (IGF-II) Interaction with the IGF-II/Mannose 6-Phosphate Receptor. THE EFFECTS OF DOMAIN 13 AND pH
J. Biol. Chem., June 22, 2001; 276(26): 23986 - 23991.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.